NCT07147582

Brief Summary

Sleep disorders and anxiety are complicated disorders affecting population especially elderly population, therefore treating these disorders will have positive impact on population production and quality of life.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Nov 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 21, 2025

Completed
8 days until next milestone

First Posted

Study publicly available on registry

August 29, 2025

Completed
2 months until next milestone

Study Start

First participant enrolled

November 1, 2025

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2026

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2026

Completed
Last Updated

November 18, 2025

Status Verified

November 1, 2025

Enrollment Period

2 months

First QC Date

August 21, 2025

Last Update Submit

November 15, 2025

Conditions

Keywords

AnxietyElderlySleep Dsorders

Outcome Measures

Primary Outcomes (1)

  • Sleep quality

    Pittsburgh Sleep Quality Index (PSQI) will be used for sleep quality assessment Higher scores indicate poorer sleep quality, with a score greater than 5 suggesting significant sleep difficulties

    before treatment and after 12 weeks

Secondary Outcomes (1)

  • Anxiety

    before treatment and after 12 weeks of treatment

Study Arms (2)

Experimental

ACTIVE COMPARATOR

Transcranial alternating current stimulation activating brain alpha wave

Other: Transcranial alternating current stimulation with two electrodes placed on scalp

control

SHAM COMPARATOR

Transcranial alternating current stimulation will not be turned on

Other: Transcranial alternating current stimulation with two electrodes placed on scalp

Interventions

Transcranial alternating current stimulation with anode and cathode electrodes and frequency ranged from 8 to 13 HZ

Experimentalcontrol

Eligibility Criteria

Age60 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • healthy elderly adult aged more than 60 years old, both sex, and suffering from insomnia and sleep disorders

You may not qualify if:

  • neurological and vascular diseases.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cairo University

Cairo, Egypt

Location

MeSH Terms

Conditions

Anxiety Disorders

Interventions

Transcranial Direct Current Stimulation

Condition Hierarchy (Ancestors)

Mental Disorders

Intervention Hierarchy (Ancestors)

Electric Stimulation TherapyTherapeuticsConvulsive TherapyPsychiatric Somatic TherapiesBehavioral Disciplines and ActivitiesElectroshockPsychological Techniques

Central Study Contacts

Salah Eid Ahmed Ali, Assistant Lecturer

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Lecturer

Study Record Dates

First Submitted

August 21, 2025

First Posted

August 29, 2025

Study Start

November 1, 2025

Primary Completion

January 1, 2026

Study Completion

February 1, 2026

Last Updated

November 18, 2025

Record last verified: 2025-11

Data Sharing

IPD Sharing
Will not share

Locations